JP2006516568A - 加齢関連性障害を処置するための組成物および方法 - Google Patents

加齢関連性障害を処置するための組成物および方法 Download PDF

Info

Publication number
JP2006516568A
JP2006516568A JP2006500781A JP2006500781A JP2006516568A JP 2006516568 A JP2006516568 A JP 2006516568A JP 2006500781 A JP2006500781 A JP 2006500781A JP 2006500781 A JP2006500781 A JP 2006500781A JP 2006516568 A JP2006516568 A JP 2006516568A
Authority
JP
Japan
Prior art keywords
composition
days
age
phospholipid
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006500781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516568A5 (https=
Inventor
デービッド エス． カン，
チョンヒ， キンバーリー カン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2006516568A publication Critical patent/JP2006516568A/ja
Publication of JP2006516568A5 publication Critical patent/JP2006516568A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2006500781A 2003-01-03 2004-01-02 加齢関連性障害を処置するための組成物および方法 Pending JP2006516568A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/336,150 US7033612B2 (en) 2003-01-03 2003-01-03 Composition and method for treating age-related disorders
PCT/US2004/000086 WO2004062626A2 (en) 2003-01-03 2004-01-02 Composition and method for treating age-related disorders

Publications (2)

Publication Number Publication Date
JP2006516568A true JP2006516568A (ja) 2006-07-06
JP2006516568A5 JP2006516568A5 (https=) 2007-02-22

Family

ID=32680944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500781A Pending JP2006516568A (ja) 2003-01-03 2004-01-02 加齢関連性障害を処置するための組成物および方法

Country Status (6)

Country Link
US (1) US7033612B2 (https=)
EP (1) EP1594473A4 (https=)
JP (1) JP2006516568A (https=)
KR (1) KR20050088153A (https=)
CN (1) CN100430046C (https=)
WO (1) WO2004062626A2 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011096413A1 (ja) * 2010-02-03 2011-08-11 花王株式会社 運動機能改善剤
JP2012513454A (ja) * 2008-12-22 2012-06-14 フィリップ ペロヴィッチ 脂質低下薬を経口腔粘膜投与する処方物（ｆｏｒｍｕｌａｔｉｏｎ）
WO2012090625A1 (ja) * 2010-12-28 2012-07-05 医療法人社団ブックス 認知症を血液サンプルで判定するための検査方法
JPWO2022004632A1 (https=) * 2020-06-30 2022-01-06

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120114335A (ko) * 2010-01-06 2012-10-16 마루다이 푸드 가부시키가이샤 뇌신경 세포 신생제
JP7162803B2 (ja) * 2020-06-30 2022-10-31 株式会社 レオロジー機能食品研究所 発毛及び／又は育毛用組成物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484611A (en) * 1992-07-15 1996-01-16 The Scottish Agricultural College Method of producing a fatty acid
CN1128144A (zh) * 1995-07-13 1996-08-07 来风战 鸡胎精口服液
JPH09502360A (ja) * 1994-06-27 1997-03-11 アンスティチュ ドゥ ルシェルシュ ビオロジク リン脂質をベースとした新規な食餌療法組成物と、その食物添加物としての利用
CN1194110A (zh) * 1997-03-25 1998-09-30 高尔丰 鸡胚素及其加工方法
JP2000516261A (ja) * 1997-05-06 2000-12-05 アンスティチュ ドゥ ルシェルシュ ビオロジク ソシエテ アノニム 動物リン脂質の治療および／または食事療法での新規な使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801200A (en) * 1984-03-19 1998-09-01 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
GB9000309D0 (en) 1990-01-06 1990-03-07 West Of Scotland College The Method of producing a fatty acid
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US6383810B2 (en) * 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
DE69906345T2 (de) * 1998-10-30 2004-02-12 Merck Patent Gmbh Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten
CN1228963A (zh) * 1998-12-28 1999-09-22 卢杲 一种治疗老年性痴呆症、帕金森症、心脑血管病的药物
JP2001302521A (ja) * 2000-04-24 2001-10-31 Yasutaka Sakamoto 鳥類胚抽出物を人体に応用するビジネスモデル
US6300377B1 (en) 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
DK1417211T3 (da) * 2001-07-27 2007-10-08 Neptune Technologies & Bioress Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse
KR100680121B1 (ko) * 2001-08-09 2007-02-07 데구사 푸드 인그리디언츠 게엠베하 (리소-)포스파티딜세린을 포함하는 온혈동물에서 스트레스상태의 예방 및 치료용 제제

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484611A (en) * 1992-07-15 1996-01-16 The Scottish Agricultural College Method of producing a fatty acid
JPH09502360A (ja) * 1994-06-27 1997-03-11 アンスティチュ ドゥ ルシェルシュ ビオロジク リン脂質をベースとした新規な食餌療法組成物と、その食物添加物としての利用
CN1128144A (zh) * 1995-07-13 1996-08-07 来风战 鸡胎精口服液
CN1194110A (zh) * 1997-03-25 1998-09-30 高尔丰 鸡胚素及其加工方法
JP2000516261A (ja) * 1997-05-06 2000-12-05 アンスティチュ ドゥ ルシェルシュ ビオロジク ソシエテ アノニム 動物リン脂質の治療および／または食事療法での新規な使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6010029564, ＳＩＴＩＺＹＯ， Ｋ． ｅｔ ａｌ．, Ｊ． Ｆａｃ． Ａｇｒｉｃ．， Ｔｏｔｔｏｒｉ Ｕｎｉｖ．, 1992, Ｖｏｌ．２８, ｐ．６７−７４ *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012513454A (ja) * 2008-12-22 2012-06-14 フィリップ ペロヴィッチ 脂質低下薬を経口腔粘膜投与する処方物（ｆｏｒｍｕｌａｔｉｏｎ）
WO2011096413A1 (ja) * 2010-02-03 2011-08-11 花王株式会社 運動機能改善剤
WO2012090625A1 (ja) * 2010-12-28 2012-07-05 医療法人社団ブックス 認知症を血液サンプルで判定するための検査方法
CN103314291A (zh) * 2010-12-28 2013-09-18 藤野脑研究株式会社 通过血液样品判定痴呆症用的检验方法
CN103314291B (zh) * 2010-12-28 2016-05-11 藤野脑研究株式会社 通过血液样品判定痴呆症用的检验方法
JP6025568B2 (ja) * 2010-12-28 2016-11-16 株式会社藤野ブレインリサーチ 認知症を血液サンプルで判定するための検査方法
JPWO2022004632A1 (https=) * 2020-06-30 2022-01-06
WO2022004632A1 (ja) * 2020-06-30 2022-01-06 株式会社レオロジー機能食品研究所 発毛及び／又は育毛用組成物
JP7465014B2 (ja) 2020-06-30 2024-04-10 株式会社 レオロジー機能食品研究所 発毛及び／又は育毛用組成物

Also Published As

Publication number Publication date
CN1756536A (zh) 2006-04-05
KR20050088153A (ko) 2005-09-01
US7033612B2 (en) 2006-04-25
US20040131644A1 (en) 2004-07-08
CN100430046C (zh) 2008-11-05
WO2004062626A2 (en) 2004-07-29
EP1594473A2 (en) 2005-11-16
WO2004062626A3 (en) 2005-05-19
EP1594473A4 (en) 2010-03-24

Similar Documents

Publication Publication Date Title
EP2046312B1 (en) Pharmaceutical and nutraceutical products comprising vitamin k2
US20120040014A1 (en) LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
JP2000219624A (ja) インスリン抵抗性糖尿病のための食事用補添物
JPS62265232A (ja) 脂質置換治療法
JP2021508343A (ja) リゾホスファチジルコリン組成物
CN101534807A (zh) 含有维生素k2的药品和类药剂营养品
BR112020000902B1 (pt) Composição para uso na prevenção e no tratamento de patologias do aparelho cardiovascular, e uso de uma mistura
CA2199289C (fr) Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives
JP2003012520A (ja) 抗酸化剤及びそれを含有する飲食品
CN100430046C (zh) 用于治疗与年龄相关的疾病的组合物与方法
JP7693715B2 (ja) 卵黄タンパク質由来の身長成長及び骨密度増加用組成物
WO2010084661A1 (ja) イソチオシアネート類含有組成物、食品、食品素材、医薬品、化粧品および日用品雑貨類
JP2022521119A (ja) 組織の灌流の増加における使用のためのイノシトールリン酸化合物
JPS60120995A (ja) 新規アミノ酸誘導体の製法
TWI359667B (en) Formulation for oral administration having a healt
CN101112393B (zh) 一种表面活性物质组合物莫尔尤菲及其制备方法与用途
US20060257540A1 (en) Plant seed extract composition and process for producing the same
JP2026505157A (ja) プラズマローゲンの欠乏によって引き起こされる疾患又は障害の治療の治療に使用するためのホスファチジルコリン及びホスファチジルエタノールアミンのエーテル、それらのリゾ体ならびにそれらの混合物
JPS5843385B2 (ja) シジミの薬効成分及びその製造法
JP4359205B2 (ja) 皮膚保湿用食品
KR101182046B1 (ko) 오징어젓 또는 오징어를 유효성분으로 함유하는 비만 또는 고지혈증 및 동맥경화성 혈관계 질환의 예방 및 치료용 조성물
WO2020029221A1 (zh) 具有抑制脂肪形成及抗氧化活性的组合物及其用途
JP5269297B2 (ja) ニンニク成分を含有する高血圧の予防及び／又は治療用組成物
WO2014042448A1 (ko) 포스파티딜콜린 및 바이페닐—디메틸-디카르복실레이트를 포함하는 간 질환 예방 또는 치료용 조성물 및 이의 용도
JP2005232085A (ja) 活性酸素低減剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100531

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101025